Featured Firms
Presented by BigVoodoo
The federal pre-emption issue may soon come to a head at the 9th U.S. Circuit Court of Appeals in Motus v. Pfizer Inc. Regardless of how Motus is decided, there remains an important public policy question: Should the FDA adopt a regulation that pre-empts failure-to-warn claims across the board?
November 10, 2003 at 12:00 AM
1 minute read
The original version of this story was published on National Law Journal
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS